Ten Dental Predictions for 2026. What Actually Matters.

2026 is arriving fast. Here's what's actually going to happen in dental. Not what vendors will tell you. What will actually happen.

One: M&A continues but multiples compress. Buyers have optionality. Sellers don't. Prices fall 5-10 percent from 2025 peaks. Two: Tariffs impact supply costs through Q1. Material prices stay elevated. Three: AI receptionists finally hit the market at scale. Fifty percent adoption by mid-2026. Four: 3D printer vendors consolidate. Formlabs and SprintRay acquire smaller players. Five: DSOs hit maturity wall. Organic growth stalls. Rollup pace slows.

Six: Hygiene becomes the strategic battleground. Practices that can't staff hygiene can't grow production. Seven: Remote monitoring and digital patient engagement remain unproven ROI plays. Adoption stays flat. Eight: Dental school graduates still can't find decent jobs because DSO salaries are compressed. Pipeline remains constrained. Nine: Insurance reimbursement stays flat while costs climb. Margin pressure continues. Ten: Specialty practices outperform general. Ortho, perio, implant centers maintain pricing power. General dentistry commoditizes.

What does this mean for you: Defend your margins, strengthen your hygiene program, and be skeptical of technology that doesn't directly move production or case acceptance. 2026 rewards fundamentals, not hype.

Let's Unpack Each Prediction With Real Implications

1. M&A multiples compress 5-10%
PE-backed DSOs are sitting on $2.5T in dry powder, but rising interest rates (7-8% debt costs) mean used buyouts don't pencil out at 2022 valuations. Practices that sold at 8-9x EBITDA in 2022 are getting 7-7.5x offers in 2026. If you're a seller, that's $500K-1M less exit value on a $2M practice. If you're a buyer, it's an opportunity to acquire at better prices than 24 months ago.

2. Tariffs elevate supply costs Q1-Q2
25% tariffs on Chinese dental supplies (burs, composite, disposables) hit in January 2026. Suppliers pass costs to practices. Your supply budget increases 8-12%. If you're spending $120K/year on supplies, that's $10K-14K in cost inflation. Hedge now: order 90-120 days of inventory at 2025 prices, renegotiate supplier contracts for volume discounts.

3. AI receptionists hit 50% adoption
Cost drops to $200-400/month. ROI is undeniable (saves $50K/year in labor or redeploys staff to revenue-generating tasks). Early adopters report 15-20% production gains from freed-up staff time. Laggards who don't adopt will be at a structural disadvantage by Q4.

4. 3D printer vendor consolidation
Formlabs and SprintRay are the survivors. Smaller players (EnvisionTEC, Asiga) get acquired or exit the market. If you own a printer from a smaller vendor, plan for reduced support and limited consumable availability. Consider switching to Formlabs/SprintRay in 2026-2027 before your current vendor folds.

5. DSO organic growth stalls
DSO platforms that grew 20-30% annually via acquisition are hitting operational limits. They can't find enough qualified dentists to staff new locations. They can't integrate acquisitions fast enough. Growth slows to 5-10% organic (same-store sales). This opens opportunity for high-performing independent practices to compete and win on patient experience.

6. Hygiene is the bottleneck
Hygiene school enrollment is down 12% since 2022. Hygienists are harder to find and more expensive ($65K-75K salary + benefits). Practices that can't staff hygiene chairs can't grow production, period. If you lose your hygienist and can't replace them in 60 days, your production drops 20-30%. Invest in hygiene retention now: better pay, better scheduling, better benefits.

7. Remote monitoring stays unproven
Vendors sell remote monitoring (for aligners, oral health tracking) as the future. Reality: patients don't comply. Adoption rates are 15-20%. ROI is negative for most practices. Skip the hype unless you're in a niche market (high-compliance patient base, tech-forward demographic).

8. New dentist pipeline stays constrained
Dental school applications are flat. Graduates can't afford to buy practices (8-9x EBITDA at $2M = $16M+ purchase price). DSOs offer $140K-160K salaries, but associates want ownership pathways. Pipeline of available associates stays tight. If you need an associate, hire now or pay 15% more in 2027.

9. Insurance reimbursement flat, costs up 5-7%
PPO fee schedules stay flat or increase 1-2%. Your costs (staff, supplies, rent) increase 5-7%. The spread compresses your margins 3-5 points annually. If you're at 35% EBITDA today and don't cut costs or raise prices, you'll be at 28-30% by 2028. Defend margins aggressively or go out-of-network.

10. Specialty practices outperform general dentistry
Ortho, perio, and implant centers maintain pricing power (less insurance dependence, higher case values). General dentistry becomes commoditized (insurance-driven, low margin, high competition). If you're general dentistry, differentiate (cosmetic focus, high-touch service, niche market) or accept lower margins.

OPERATOR MATH

Let's model the cumulative impact of these trends on a typical $1.5M general dentistry practice over 2026-2028.

Baseline 2025:
Revenue: $1.5M
Labor: $525K (35%)
Supplies: $120K (8%)
Rent: $180K (12%)
Other overhead: $225K (15%)
EBITDA: $450K (30%)

2026 impact (if you do nothing):
Revenue: $1.5M (flat, hygiene bottleneck limits growth)
Labor: $560K (+7%, wage inflation + turnover)
Supplies: $134K (+12%, tariff impact)
Rent: $186K (+3%, lease escalator)
Other: $232K (+3%, general inflation)
EBITDA: $388K (25.9%, -4.1 points)

2027 impact (continued decline):
Revenue: $1.5M (still flat, can't staff hygiene)
Labor: $595K (+6.3%, continued pressure)
Supplies: $141K (+5%)
Rent: $192K (+3%)
Other: $239K (+3%)
EBITDA: $333K (22.2%, -7.8 points vs 2025)

2028 impact:
EBITDA: $280K (18.7%, -11.3 points vs 2025)

Three-year margin erosion: -$170K annually, -11.3 EBITDA points

Now model defensive strategy (adopt AI receptionist, renegotiate supplies, hire hygienist at premium, cut low-margin procedures):

2026 with defensive actions:
Revenue: $1.65M (+10%, hygiene hired and productive)
Labor: $540K (AI receptionist saves $20K, hygienist adds $50K cost, net +$30K but revenue up $150K)
Supplies: $125K (renegotiated suppliers, volume discounts offset tariffs)
Rent: $180K (renegotiated flat lease)
Other: $225K (unchanged)
EBITDA: $580K (35.2%, +5.2 points vs baseline)

Three-year comparison:
Passive approach: $280K EBITDA in 2028 (-$170K vs 2025)
Defensive approach: $580K EBITDA in 2026 maintained through 2028 (+$130K vs 2025)
Delta: $300K annually by 2028

THE TAKEAWAY

Strategic actions for 2026:

• Defend margins aggressively. You can't control insurance reimbursement or cost inflation, but you can control labor efficiency (AI receptionist), supply costs (renegotiate contracts), and rent (renegotiate lease).
• Staff hygiene at any cost. Pay $5K-10K above market if necessary. A hygienist produces $150K-200K annually. Losing one costs you $150K in production. Overpaying by $10K to keep them is obvious math.
• Adopt AI receptionist now. 50% of practices will have it by year-end. If you don't, you're at a labor cost disadvantage. ROI is 10x+ in year one. Do it in Q1.
• Hedge tariff impact. Order 90-120 days of supplies at 2025 prices. Lock in volume discounts with suppliers. Switch to generic brands where clinically acceptable. Save 2-3 EBITDA points.
• Evaluate your exit timeline. If you're selling in 2026-2027, optimize EBITDA now (every point is worth $150K+ in exit value). If you're not selling, prepare to compete with DSOs who have better cost structures. Differentiate or accept lower margins.
• Skip unproven tech. Remote monitoring, digital patient engagement, blockchain dental records - all vaporware. Focus on fundamentals: production, case acceptance, labor efficiency, margin defense.

2026 will separate high-performing practices from mediocre ones. The difference: disciplined cost management, aggressive hygiene staffing, and strategic technology adoption (AI receptionist, verification automation). The practices that execute these fundamentals will grow EBITDA 5+ points. The ones that don't will lose 5+ points. The gap is $300K+ annually. Choose your path now.